Reboxetine and Citalopram as an Adjunct Treatment to Second Generation Antipsychotics in the Treatment of Negative Symptoms of Schizophrenia

NCT01300364 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

249

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Reboxetine
DRUG: citalopram (SSRI)

Sponsor

Fundació Sant Joan de Déu

Collaborators

[object Object]